(Q52044177)

20 April 2018

title

The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. (English)

1 reference

20 April 2018

author name string

Carballido JM

1

1 reference

20 April 2018

Faith A

2

1 reference

20 April 2018

Carballido-Perrig N

3

1 reference

20 April 2018

Blaser K

4

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

20 April 2018

European Journal of Immunology

published in

1 reference

20 April 2018

volume

27

1 reference

20 April 2018

issue

2

1 reference

20 April 2018

page(s)

515-521

1 reference

20 April 2018

Lymphocyte responses and cytokines

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Regulation of immunity to parasites by T cells and T cell-derived cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Coexpression of granulocyte-macrophage colony-stimulating factor, gamma interferon, and interleukins 3 and 4 is random in murine alloreactive T-lymphocyte clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

The relationship of IL-4- and IFNγ-producing T cells studied by lineage ablation of IL-4-producing cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Regulation of the development of type 2 T-helper cells in allergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Analysis of the cDNA for phospholipase A2 from honeybee venom glands. The deduced amino acid sequence reveals homology to the corresponding vertebrate enzymes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Allergy to insect stings. II. Phospholipase A: the major allergen in honeybee venom

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Mapping human T cell epitopes on phospholipase A2: the major bee-venom allergen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Carbohydrate-dependent, HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

B Lymphoblasts show Oxidase Activity in Response to Cross‐Linking of Surface IgM and HLA‐DR

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

An HLA-associated nonresponsiveness to mellitin: a component of bee venom

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Selective activation of Th1- and Th2-like cells in vivo--response to human collagen IV.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Antigen-specific interaction between T and B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Phospholipase A2 at the bilayer interface

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

New perspectives of CD28-B7-mediated T cell costimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Lymphokine production by human T cells in disease states

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Regulation of the immune response to peptide antigens: differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Peptide modulation of allergen-specific immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Antagonizing the differentiation and functions of human T helper type 2 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270224

7 January 2021

Identifiers

DOI

10.1002/EJI.1830270224

1 reference

20 April 2018

PubMed ID

9045925

1 reference

20 April 2018